Shandong Weigao Group Medical Polymer Company Limited (HKG:1066)
4.580
+0.140 (3.15%)
At close: Mar 27, 2026
HKG:1066 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 8,570 | 7,780 | 6,989 | 6,964 | 6,698 |
Short-Term Investments | 494.23 | 310.8 | 344.21 | 521.65 | 425.32 |
Trading Asset Securities | 388.82 | 230.7 | 0.37 | - | 10 |
Cash & Short-Term Investments | 9,453 | 8,322 | 7,333 | 7,486 | 7,133 |
Cash Growth | 13.59% | 13.48% | -2.04% | 4.95% | 16.27% |
Accounts Receivable | 6,359 | 6,339 | 5,960 | 5,794 | 5,191 |
Other Receivables | 678.28 | 852.98 | 770.04 | 711.56 | 522.21 |
Receivables | 7,483 | 7,506 | 7,373 | 7,133 | 6,142 |
Inventory | 2,515 | 2,528 | 2,495 | 2,324 | 1,782 |
Other Current Assets | 1,212 | 1,086 | 1,433 | 1,345 | 1,203 |
Total Current Assets | 20,663 | 19,443 | 18,634 | 18,288 | 16,260 |
Property, Plant & Equipment | 7,463 | 7,084 | 7,007 | 6,859 | 6,259 |
Long-Term Investments | 2,333 | 1,989 | 1,898 | 1,854 | 1,421 |
Goodwill | 3,701 | 3,831 | 3,728 | 3,639 | 3,348 |
Other Intangible Assets | 1,045 | 1,183 | 1,337 | 1,575 | 1,681 |
Long-Term Accounts Receivable | 4.95 | 12.97 | 15.3 | 23.04 | 40.96 |
Long-Term Deferred Tax Assets | 259.66 | 248.54 | 207.1 | 161.24 | 157.04 |
Long-Term Deferred Charges | - | 122.04 | 170.16 | 147.2 | 117.36 |
Other Long-Term Assets | 266.57 | 434.27 | 526.88 | 672.36 | 974.12 |
Total Assets | 36,048 | 34,760 | 33,670 | 33,402 | 30,578 |
Accounts Payable | 4,490 | 2,094 | 1,770 | 1,712 | 1,627 |
Accrued Expenses | - | - | - | 1,045 | 1,029 |
Current Portion of Long-Term Debt | 432.61 | 1,203 | 2,547 | 960.81 | 601.33 |
Current Portion of Leases | 65.81 | 38.94 | 26.59 | 29.32 | 22.99 |
Current Income Taxes Payable | 136.57 | 178.79 | 239.96 | 193.92 | 150.67 |
Current Unearned Revenue | 333.21 | 359 | 431.86 | 393.55 | 325.84 |
Other Current Liabilities | 14.36 | 2,207 | 2,567 | 1,670 | 1,420 |
Total Current Liabilities | 5,472 | 6,081 | 7,582 | 6,005 | 5,178 |
Long-Term Debt | 4,357 | 2,800 | 1,495 | 3,397 | 3,455 |
Long-Term Leases | 248.49 | 151.04 | 100.68 | 104.08 | 57.86 |
Long-Term Unearned Revenue | 58.5 | 64.34 | 69.71 | 76.74 | 94.45 |
Long-Term Deferred Tax Liabilities | 66.07 | 89.63 | 165.79 | 199.8 | 222.62 |
Other Long-Term Liabilities | 26.52 | 232.47 | 264 | 37 | 522.65 |
Total Liabilities | 10,228 | 9,418 | 9,678 | 9,820 | 9,531 |
Common Stock | 457.06 | 457.06 | 457.06 | 457.06 | 457.06 |
Additional Paid-In Capital | - | 2,743 | 2,743 | 2,743 | 2,743 |
Retained Earnings | 9,866 | 20,116 | 18,889 | 17,574 | 15,444 |
Comprehensive Income & Other | 13,785 | 435.33 | 360.11 | 992.76 | 762.56 |
Total Common Equity | 24,108 | 23,752 | 22,449 | 21,767 | 19,407 |
Minority Interest | 1,711 | 1,590 | 1,544 | 1,815 | 1,640 |
Shareholders' Equity | 25,820 | 25,342 | 23,993 | 23,582 | 21,047 |
Total Liabilities & Equity | 36,048 | 34,760 | 33,670 | 33,402 | 30,578 |
Total Debt | 5,103 | 4,193 | 4,169 | 4,491 | 4,138 |
Net Cash (Debt) | 4,349 | 4,129 | 3,164 | 2,995 | 2,996 |
Net Cash Growth | 5.34% | 30.49% | 5.65% | -0.03% | 65.65% |
Net Cash Per Share | 0.96 | 0.91 | 0.70 | 0.66 | 0.66 |
Filing Date Shares Outstanding | 4,528 | 4,571 | 4,571 | 4,571 | 4,571 |
Total Common Shares Outstanding | 4,528 | 4,571 | 4,571 | 4,571 | 4,571 |
Working Capital | 15,190 | 13,362 | 11,052 | 12,282 | 11,082 |
Book Value Per Share | 5.32 | 5.20 | 4.91 | 4.76 | 4.25 |
Tangible Book Value | 19,362 | 18,738 | 17,384 | 16,553 | 14,377 |
Tangible Book Value Per Share | 4.28 | 4.10 | 3.80 | 3.62 | 3.15 |
Land | - | 8.89 | 8.63 | 8.49 | 7.77 |
Buildings | - | 4,024 | 3,935 | 3,844 | 3,781 |
Machinery | - | 5,615 | 5,002 | 4,668 | 3,932 |
Construction In Progress | - | 839.47 | 1,004 | 769.56 | 577.14 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.